Comparison of Thrombectomy and Standard Care for Ischemic Stroke in Patients Ineligibility for Tissue Plasminogen Activator Treatment "THRILL"

Suspended

Phase N/A Results N/A

Summary of Purpose

the purpose of this study is to to compare the safety and effectiveness of stent-retrievers as a device class group with best medical care alone in the treatment of acute ischemic stroke (AIS) in patients who are not eligible for IV-tPA up to 8 hours of symptom onset. Trial Stopped: Recruitment is on hold until MR CLEAN, ESCAPE, EXTEND-IA, and SWIFt PRIME have been evaluated.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 January 2015.

1 Mar 2014 30 Apr 2014 1 Feb 2018 1 Mar 2018 1 Jan 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts